Dow Inc. Reports Q3 2026 Financial Results with Significant Operating Profit Rebound

Executive Summary

On October 22, 2026, Dow Inc. filed Form 8-K under Item 2.02 (Results of Operations and Financial Condition) disclosing its financial performance for the third quarter ended September 30, 2026. The results demonstrated substantial year-over-year recovery driven by local price realization, cost-reduction execution, and downstream margin expansion across all operating segments.

Key Financial Highlights

• Net Sales: $11,267 million, up 13.0% YoY from $9,973 million in Q3 2025.
• Pricing & Volume: Local pricing rose 14% YoY, led by Packaging & Specialty Plastics (polyethylene price gains globally). Overall volume declined 1% YoY due to Middle East logistics and conflict impacts in Asia Pacific, offsetting volume gains elsewhere.
• Operating EBIT: Reached $887 million, up $707 million compared to $180 million in Q3 2025, benefiting from company self-help programs and pricing.
• Operating EBITDA: $1,553 million, up $685 million YoY from $868 million.
• GAAP Net Income & EPS: Net income attributable to Dow was $525 million ($0.62 per share), versus $124 million ($0.08 per share) in the prior-year period.
• Operating EPS: $0.71 per share, rebounding from $(0.19) per share in Q3 2025.
• Cash Generation & Capital Return: Operating cash flow from continuing operations reached $1,839 million, while Free Cash Flow stood at $1.1 billion. The company distributed $253 million in dividends.

Segment Performance

1. Packaging & Specialty Plastics:
   • Net Sales: $5,778 million (+18.1% YoY from $4,891 million).
   • Operating EBIT: $585 million (+194% YoY from $199 million), driven by integrated polyethylene margin expansion.
2. Industrial Intermediates & Infrastructure:
   • Net Sales: $3,058 million (+7.9% YoY from $2,834 million).
   • Operating EBIT: $176 million (rebounded from a loss of -$47 million in Q3 2025), aided by self-help initiatives and suspension of Sadara equity loss recognition.
3. Performance Materials & Coatings:
   • Net Sales: $2,250 million (+8.1% YoY from $2,082 million).
   • Operating EBIT: $154 million (+92.5% YoY from $80 million), supported by downstream silicones demand and closure of high-cost upstream capacity (Barry, U.K. facility).

Strategic Initiatives and Outlook

Management reiterated that its multi-year transformation programs, including the $1 billion 2025 cost reduction plan and "Transform to Outperform," are delivering expected results, targeting over $1 billion of EBITDA uplift in both 2026 and 2027 alongside targeted growth in AI infrastructure, packaging, and mobility end-markets.